In a paper published Monday in the American Journal of Preventive Medicine, the scientists at UCSD Herbert Wertheim School of ...
Taking silly selfies with a beloved friend, laughing as we posed for the camera, my eyes sparkling, my smile bright, I felt a jolt of recognition. There you are, I thought; I've missed you. Because ...
A Health Canada-approved clinical trial is seeking 20 local participants who have been diagnosed with post-traumatic stress ...
Americans' interest in a potentially harmful "magic mushroom" is soaring, with Google searches skyrocketing 114% from 2022 to ...
Researchers to work with 50 patients, mostly veterans and first responders with mental health concerns like depression and ...
A year in, Oregon’s experiment with the first regulated psilocybin mushroom market in the world is short on customers. To ...
What creates bliss for one is a bad trip to another. New findings help to clarify how psilocybin activates regions of the ...
[ { "name": "Air - MediumRectangle - Inline Content - Mobile Display Size", "component": "18478561", "insertPoint": "2", "requiredCountToDisplay": "2" },{ "name ...
A bill was introduced in the state senate this year to legalize supervised treatments of psychedelic mushrooms.
In an intriguing development, researchers are exploring the potential of psychedelics as a treatment for long Covid symptoms.
A type of "magic mushroom" is gaining interest in the United States, but scientists at UC San Diego warned Monday it may not be the one people think they are purchasing. In a paper published Monday in ...